Insulin Lispro Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Insulin Lispro Injection (injection) from Eli Lilly And Co. with status No longer listed by FDA. The shortage was first posted on Oct 24, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Eli Lilly And Co.
- Package NDC
- 0002-8213-05
- Dosage Form
- Injection
- Presentation
- Humalog, Injection, U-100 Tempo Pen (NDC 0002-8213-05)
- Initial Posting
- Oct 24, 2025